Accesibilidad y comodidad de lectura.

Tamano del texto

Modo claro/oscuro

Espaciado vertical de líneas

¿Tiene problemas para utilizar nuestro sitio web?
Contáctenos

Dra. Claudia Priglinger

In esta página

Información del miembro

Dr Claudia Priglinger

Representante

Alemania

Equipo

Dr Maximilian Gerhardt

Alemania

Ver más

Centro HCP

El hospital LMU con sus dos sedes en Múnich, Campus Großhadern y Campus Innenstadt, es uno de los hospitales universitarios más grandes de Alemania y...

contacte

Klinikum der Universität München, Germany

Mathildenstraße 8
80336 Munich
Germany

Los ensayos clínicos

NCT03406104 Completado

Long-term Follow-up of ND4 LHON Subjects Treated With GS010 Ocular Gene Therapy in the RESCUE or REVERSE Phase III Clinical Trials (RESTORE)

Intervencionista
Ver la prueba
ver la ficha
NCT03364153 Activo, no reclutando

A Phase 2b Randomized, Double-masked, Controlled Trial to Establish the Safety and Efficacy of Zimura™ (Complement C5 Inhibitor) Compared to Sham in Subjects With Autosomal Recessive Stargardt Disease

Intervencionista
Ver la prueba
ver la ficha

NCT04435366 Completado

A Phase 3 Multicenter, Randomized, Double Masked, Sham- Controlled Clinical Trial to Assess the Safety and Efficacy of Intravitreal Administration of Zimura (Complement C5 Inhibitor) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Intervencionista
Ver la prueba
ver la ficha
NCT05536297 Activo, no reclutando

Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy

Intervencionista
Ver la prueba
ver la ficha
NCT04276558 Reclutamiento, Activo

Efficacy, Safety and Pharmacokinetics of 3 Doses of REC 0/0559 Eye Drops for the Treatment of Stage 2 (Moderate) and 3 (Severe) Neurotrophic Keratitis in Adult Patients

Intervencionista
Ver la prueba
ver la ficha
NCT03525600 Completado

A Phase 3, Multi-Center, Randomized, Double-Masked, Sham-Controlled Study to Compare the Efficacy and Safety of Intravitreal Pegcetacoplan Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)

Intervencionista
Ver la prueba
ver la ficha
NCT04770545 Activo, no reclutando

A Phase 3, Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Pegcetacoplan in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Intervencionista
Ver la prueba
ver la ficha
DRKS00023562 Reclutamiento, Activo

Evaluation of the effectiveness of transcorneal electrostimulation in patients with retinitis pigmentosa - a multicenter, prospective, randomized, controlled and double-blind study on behalf of the G-BA

Intervencionista
Ver la prueba
ver la ficha
NCT02686658 Completado

A Phase 2/3 Randomized, Double-Masked, Controlled Trial to Assess the Safety and Efficacy of Intravitreous Administration of Zimura™ (Anti-C5 Aptamer) in Subjects With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration

Intervencionista
Ver la prueba
ver la ficha
NCT01756456 Completado

Evaluation of safety and efficacy of r-hNGF in patients with stage 2 and 3 Neurotrophic Keratitis (REPARO).

Intervencionista
Ver la prueba
ver la ficha
NCT04639635 Reclutamiento, Activo

Study of CNGB1 Retinitis Pigmentosa and Allied Hereditary Disorders

De observación
Ver la prueba
ver la ficha
NCT04939571 Reclutamiento, Activo

European Disease Registry on Retinopathy of Prematurity (ROP)

De observación
Ver la prueba
ver la ficha